EXPONENT INC (EXPO) Form 10-Q — Aug 7, 2026
Exponent reported Q2 2026 revenues of $171.6 million, up 21% year over year, with net income of $29.4 million (up 11%) and diluted EPS of $0.60 versus $0.52 a year ago. Revenues before reimbursements grew 12% to $148.9 million. Growth was led by the Engineering and Other Scientific segment, where revenue rose 23% to $148.8 million on demand for user research studies tied to AI-enabled consumer electronics products plus utility-sector risk management work. Utilization improved to 74% from 72% and billable hours rose 9%.
Key figures
- Eps
- 0.6
- Revenue
- 171612000
- Net Income
- 29395000
- Revenue Yoy
- 21%
- Total Assets
- 652723000
- Cash Position
- 66629000
- Shares Outstanding
- 47546084
- Q2 ebitdas
- 49408000
- Utilization q2
- 74%
- Billable hours q2
- 390000
- Six month ebitdas
- 101602000
- Six month revenue
- 337915000
- Billable hours yoy
- 9%
- Q2 operating income
- 28022000
- Six month net income
- 58964000
- Effective tax rate q2
- 27.9%
- Six month diluted eps
- 1.19
- Six month revenue yoy
- 17.5%
- Q2 avg repurchase price
- 59.88
- Q2 operating income yoy
- 63.1%
- New buyback authorization
- 50000000
- Six month share repurchases
- 146138000
- Top client concentration q2
- 11%
- Engineering segment q2 growth
- 23.0%
- Engineering segment q2 revenue
- 148829000
- Environmental health q2 growth
- 8.6%
- Dividends declared per share q2
- 0.31
- Environmental health q2 revenue
- 22783000
Price after filing
Close on the filing date to close N calendar days later (from $66.79). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.